Potential anti-gout properties of Wuwei Shexiang pills based on network pharmacology and pharmacological verification

被引:18
作者
Bai, Lijie [1 ]
Wu, Chen [1 ]
Lei, Shuhui [1 ]
Zou, Min [1 ]
Wang, Shengjun [2 ]
Zhang, Zhongyun [1 ]
Bao, Zilu [1 ]
Ren, Zhaoxiang [1 ]
Liu, Kaiqun [1 ]
Ma, Qianjiao [1 ]
Ou, Hongyue [1 ]
Lan, Zhou [3 ]
Wang, Qian [4 ]
Chen, Lvyi [1 ]
机构
[1] South Cent Minzu Univ, Sch Pharmaceut Sci, Wuhan, Peoples R China
[2] Li Shizhen Pharmaceut Grp Co Ltd, Huanggang, Peoples R China
[3] Hubei Univ Chinese Med, Sch Pharm, Wuhan, Peoples R China
[4] Zhongnan Univ Econ & Law, Sch Informat & Safety Engn, Wuhan 430073, Hubei, Peoples R China
基金
中国国家自然科学基金;
关键词
Wuweishexiang pills; Gout; Network pharmacology; Pharmacological validation; KAPPA-B; GOUT; HYPERURICEMIA; EPIDEMIOLOGY; INFLAMMATION; PREVALENCE; ACTIVATION; MECHANISMS; CULTURE;
D O I
10.1016/j.jep.2023.116147
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Ethnopharmacological relevance: Wuwei Shexiang Pills (WWSX), a classic Tibetan medicine, consists of Chebulae Fructus (removed pit), Aucklandiae Radix, Moschus, Aconiti Fiavi Radix, and Acori Calami Rhizoma. It is used clinically in China to treat joint pain, swelling and other symptoms, and has the function of dispelling wind and relieving pain. However, to date, the mechanism of how it works against gout is still unclear. Aims of the study: Using network pharmacology, molecular docking and pharmacological verification to explore the potential anti-gout properties of WWSX.Materials and methods: With the use of UPLC-Q/TOF-MS, the main components of WWSX were obtained and screened for potential anti-inflammatory components by network pharmacology and molecular docking. The anti-inflammatory activity of the components screened from WWSX was also tested by in vitro assays. The anti -gout mechanism of WWSX was predicted by network pharmacology, and the pharmacological validation ex-periments using gouty arthritis model and mouse air pouch model were used to explore the multifaceted mechanism of WWSX to modify gout.Result: Thirty-eight active ingredients were obtained from the UPLC-Q/TOF-MS detection. The network phar-macology and molecular docking analysis showed that 104 co-targets were participated in the treatment of gout, and the main signaling pathways involved were NOD-like receptor pathway, NF-Kappa B pathway and MAPK pathway. Pharmacological evaluation showed that WWSX could significantly improve gout in gouty arthritis models and mouse air pouch models by modulating the above pathways.Conclusion: This work has predicted and validated the anti-inflammatory material basis and predicted the anti -gout mechanism of WWSX which was verified by network pharmacology, molecular docking and in vitro cellular studies. The results reveal the mechanism of WWSX in the treatment of gout and provide a theoretical basis for its clinical application.
引用
收藏
页数:11
相关论文
共 43 条
[1]   The Impact of Uric Acid and Hyperuricemia on Cardiovascular and Renal Systems [J].
Agnoletti, Davide ;
Cicero, Arrigo F. G. ;
Borghi, Claudio .
CARDIOLOGY CLINICS, 2021, 39 (03) :365-376
[2]   Kaempferol as a Dietary Anti-Inflammatory Agent: Current Therapeutic Standing [J].
Alam, Waqas ;
Khan, Haroon ;
Shah, Muhammad Ajmal ;
Cauli, Omar ;
Saso, Luciano .
MOLECULES, 2020, 25 (18)
[3]  
[Anonymous], 2008, Curr Protoc Immunol Chapter 14
[4]  
Arita Masanori, 2011, Genome Inform, V25, P1
[5]   Impact of comorbidities on gout and hyperuricaemia: an update on prevalence and treatment options [J].
Bardin, Thomas ;
Richette, Pascal .
BMC MEDICINE, 2017, 15
[6]   Mechanisms of disease - Nuclear factor-kappa b - A pivotal transcription factor in chronic inflammatory diseases [J].
Barnes, PJ ;
Larin, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (15) :1066-1071
[7]   Cutting Edge: Reactive Oxygen Species Inhibitors Block Priming, but Not Activation, of the NLRP3 Inflammasome [J].
Bauernfeind, Franz ;
Bartok, Eva ;
Rieger, Anna ;
Franchi, Luigi ;
Nunez, Gabriel ;
Hornung, Veit .
JOURNAL OF IMMUNOLOGY, 2011, 187 (02) :613-617
[8]   Cutting Edge: NF-κB Activating Pattern Recognition and Cytokine Receptors License NLRP3 Inflammasome Activation by Regulating NLRP3 Expression [J].
Bauernfeind, Franz G. ;
Horvath, Gabor ;
Stutz, Andrea ;
Alnemri, Emad S. ;
MacDonald, Kelly ;
Speert, David ;
Fernandes-Alnemri, Teresa ;
Wu, Jianghong ;
Monks, Brian G. ;
Fitzgerald, Katherine A. ;
Hornung, Veit ;
Latz, Eicke .
JOURNAL OF IMMUNOLOGY, 2009, 183 (02) :787-791
[9]   The mechanisms of inflammation in gout and pseudogout (CPP-induced arthritis) [J].
Busso, N. ;
Ea, H. -K. .
REUMATISMO, 2011, 63 (04) :230-237
[10]   Mechanisms of inflammation in gout [J].
Busso, Nathalie ;
So, Alexander .
ARTHRITIS RESEARCH & THERAPY, 2010, 12 (02)